Bio Competitors

BIOV Stock

ILS 29.80 0.00 0.00%

Bio View competes with Hiron Trade, Sure Tech, Amir Marketing, Adgar Investments, and One Software; as well as few others. The company operates under Health Care Equipment & Supplies sector and is part of Health Care industry. Analyzing Bio View competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Bio View to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Bio View Correlation with its peers.

You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Bio View competition on your existing holdings.

Specify up to 10 symbols:

Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Bio View's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.

Hype

Prediction

Low	Estimated	High
27.59	29.80	32.01

Details

Intrinsic

Valuation

Low	Real	High
23.54	25.75	32.78

Details

Naive

Forecast

Low	Next	High
26.06	28.27	30.48

Details

Bollinger

Band Projection (param)

Lower	Middle Band	Upper
26.82	28.57	30.31

Details

Please note, it is not enough to conduct a financial or market analysis of a single entity such as Bio View. Your research has to be compared to or analyzed against Bio View's peers to derive any actionable benefits. When done correctly, Bio View's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Bio View.

Bio View Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Bio View and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Bio and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Bio View does not affect the price movement of the other competitor.

	HRON	STEC	AMRK	ADGR	MTAV	ONE	DISI
HRON		-0.61	0.52	0.35	0.52	0.68	-0.63	HRON
STEC	-0.61		-0.53	-0.31	-0.17	-0.59	0.73	STEC
AMRK	0.52	-0.53		-0.09	0.61	0.84	-0.45	AMRK
ADGR	0.35	-0.31	-0.09		0.06	0.24	-0.17	ADGR
MTAV	0.52	-0.17	0.61	0.06		0.79	-0.36	MTAV
ONE	0.68	-0.59	0.84	0.24	0.79		-0.54	ONE
DISI	-0.63	0.73	-0.45	-0.17	-0.36	-0.54		DISI
	HRON	STEC	AMRK	ADGR	MTAV	ONE	DISI

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

High positive correlations

ONE	+ 0.84	AMRK
ONE	+ 0.79	MTAV
DISI	+ 0.73	STEC
ONE	+ 0.68	HRON
MTAV	+ 0.61	AMRK
AMRK	+ 0.52	HRON

High negative correlations

DISI	- 0.63	HRON
STEC	- 0.61	HRON
ONE	- 0.59	STEC
DISI	- 0.54	ONE
AMRK	- 0.53	STEC
DISI	- 0.45	AMRK

Risk-Adjusted Indicators

There is a big difference between Bio Stock performing well and Bio View Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Bio View's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
HRON	1.15	0.02	(0.01)	0.13	1.64	(1.63)	2.78	(3.60)	10.89
STEC	1.73	0.18	0.06	0.48	1.73	(2.60)	5.39	(3.93)	18.07
AMRK	1.37	0.47	0.23	(0.68)	1.10	(1.73)	3.75	(2.15)	11.38
ADGR	1.49	(0.05)	0.00	(0.47)	0.00	0.00	3.54	(3.20)	9.50
MTAV	1.43	0.31	0.16	1.89	1.18	(1.83)	3.64	(2.63)	7.88
ONE	1.66	0.16	0.06	0.55	1.69	(1.95)	4.45	(2.93)	11.82
DISI	1.80	0.00	(0.01)	0.08	1.70	(2.19)	5.77	(2.76)	21.64

Bio View Competitive Analysis

The better you understand Bio View competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Bio View's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Bio View's competition over several years is one of the best ways to analyze its investment potential.

Better Than Average

Worse Than Peers

View Performance Chart

	BIOV	HRON	STEC	AMRK	ADGR	MTAV	ONE	DISI
	0.00 29.80 Bio	0.04 199,880 Hiron	0.00 799.00 Sure	0.04 2,428 Amir	0.53 496.70 Adgar	1.88 1,666 MEITAV	3.16 5,214 One	0.75 350.00 Discount
Market Volatility (90 Days Market Risk)	Very steady	Very steady	Very steady	Very steady	Very steady	Very steady	Very steady	Very steady
Market Performance (90 Days Performance)	Very Weak	OK	Very Weak	Solid	Insignificant	OK	OK	Very Weak
Odds of Financial Distress (Probability Of Bankruptcy)	Low	Low	Low	Low	Below Average	Unknown	Low	Low
Current Valuation (Equity Enterprise Value)	Over Valued	Over Valued	Over Valued	Over Valued	Over Valued	Under Valued	Over Valued	Under Valued
Buy or Sell Advice (Average Analysts Consensus)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available
Trade Advice (90 Days Macroaxis Advice)	Strong Sell	Strong Sell	Strong Sell	Cautious Hold	Strong Sell	Buy	Hold	Cautious Hold
Current Ratio	2.14 X	0.32 X	N/A	1.34 X	0.64 X		1.23 X	2.17 X
Net Asset	40.02 M	1.19 B	N/A	852.81 M	4.93 B		1.91 B	18.22 B
Profit Margin	0.04 %	0.97 %	N/A	0.03 %	0.69 %		0.05 %	0.11 %
EBITDA	4.72 M	166.43 M	N/A	92.71 M	207.79 M		309.03 M	2.46 B
Operating Margin	0.02 %	0.38 %	N/A	0.04 %	0.71 %		0.07 %	0.28 %
Current Valuation	35.4 M	977.03 M	N/A	1.7 B	4.07 B		3.59 B	16.8 B
Price To Book	1.72 X	0.96 X	N/A	4.25 X	0.65 X		5.77 X	0.34 X
Retained Earnings	(29 M)	473 M	N/A	167 M	629 M		210 M	(3.12 B)
Current Asset	26 M	53 M	N/A	505 M	186 M		587 M	8.87 B
Five Year Return	N/A	1.06 %	N/A	5.49 %	N/A		4.59 %	8.00 %
Beta	0.53	0.38	N/A	0.61	0.81		0.41	0.99
Number Of Employees	35	30	N/A	219	121		6.3 K	24
Shares Outstanding	13.75 M	481.16 K	2.19 M	63.89 M	164.74 M		71.81 M	141.52 M
Cash Flow From Operations	3.25 M	41.67 M	N/A	27.64 M	96.08 M		286.84 M	1.27 B
Annual Yield	N/A	0.02 %	N/A	0.05 %	0.07 %		0.03 %	0.04 %
Total Debt	2.57 M	112.21 M	N/A	121.19 M	2.86 B		204.71 M	8.27 B
Return On Equity	0.0399	0.15	N/A	0.0905	0.14		0.29	0.4
Z Score	12.0	4.8	N/A	8.2	N/A		10.0	N/A
Return On Asset	0.0091	0.0285	N/A	0.035	0.0241		0.078	0.0511
Book Value Per Share	2.00 X	1,973 X	N/A	28.57 X	8.91 X		8.27 X	17.57 X
Current Liabilities	8 M	131 M	N/A	378 M	418 M		406 M	8.53 B
Total Asset	40.02 M	1.19 B	N/A	852.81 M	4.93 B		1.91 B	18.22 B
Debt To Equity	11.80 %	0.14 %	N/A	39.60 %	281.50 %		60.70 %	354.60 %
Last Dividend Paid	N/A	40.0	N/A	1.15	0.36		1.45	N/A
Target Price	N/A	N/A	N/A	N/A	6.5		N/A	66.75
Shares Owned By Institutions	N/A	7.57 %	4.81 %	7.32 %	25.00 %		31.80 %	N/A
Market Capitalization	53.86 M	934.89 M	17.39 M	1.54 B	804.29 M		3.25 B	842.62 M
Price To Earning	N/A	915.60 X	N/A	N/A	941.56 X		N/A	124.62 X
Price To Sales	1.71 X	6.20 X	N/A	1.29 X	3.32 X		1.10 X	0.11 X
Net Income	2.18 M	127.55 M	N/A	57.15 M	202.25 M		131.27 M	266 M
Earnings Per Share	0.09 X	340.27 X	N/A	2.64 X	1.14 X		2.19 X	7.39 X
Shares Owned By Insiders	51.58 %	81.66 %	24.26 %	71.90 %	52.49 %		44.97 %	82.75 %
Revenue	30.51 M	245.19 M	N/A	1.18 B	264.73 M		2.72 B	5.38 B
Working Capital	18 M	(78 M)	N/A	127 M	(232 M)		181 M	338 M
Cash And Equivalents	17.67 M	234 K	N/A	16.71 M	166.85 M		125.84 M	6.63 B
Cash Per Share	1.24 X	0.59 X	N/A	1.33 X	1.28 X		18.53 X	42.76 X
Gross Profit	17.59 M	78.94 M	N/A	178.37 M	238.99 M		441.94 M	2.3 B
Day Typical Price	29.53	199893.0	806.0	2428.33	495.83	1675.0	5266.33	350.9
Accumulation Distribution	0.0268	0.001	0.0256	4.0E-4	0.0144	0.023	0.034	0.025
Market Facilitation Index	0.8	200.0	21.0	1.0	7.2	39.0	183.0	8.9
Daily Balance Of Power	N/A	0.4	N/A	(1.00)	0.3611	(0.82)	(0.93)	0.2921
Period Momentum Indicator	N/A	80.0	N/A	(1.00)	2.6	(32.00)	(170.00)	2.6
Rate Of Daily Change	1.0	1.0	1.0	1.0	1.01	0.98	0.97	1.01
Day Median Price	29.4	199900.0	809.5	2428.5	495.4	1679.5	5292.5	351.35
Price Action Indicator	0.4	20.0	(10.50)	(1.00)	2.6	(29.50)	(163.50)	(0.05)
Coefficient Of Variation	(1,408)	3424.44	1233.66	439.61	(6,490)	540.4	1133.73	4719.19
Mean Deviation	1.65	1.15	1.73	1.37	1.49	1.43	1.66	1.8
Jensen Alpha	(0.18)	0.0179	0.1805	0.4702	(0.05)	0.3128	0.1638	(0.0009)
Total Risk Alpha	(0.44)	(0.19)	(0.13)	0.1851	(0.29)	0.0996	(0.09)	(0.32)
Sortino Ratio	N/A	(0.01)	0.0578	0.2271	N/A	0.1589	0.0609	(0.01)
Downside Variance	N/A	9.85	5.67	2.3	N/A	2.44	3.44	3.19
Standard Deviation	2.21	1.86	2.78	1.9	1.97	1.82	2.28	3.04
Kurtosis	1.37	2.57	7.48	2.4	1.4	(0.13)	1.1	18.92
Potential Upside	3.18	2.78	5.39	3.75	3.54	3.64	4.45	5.77
Treynor Ratio	(0.88)	0.1306	0.4802	(0.68)	(0.47)	1.89	0.5506	0.0766
Maximum Drawdown	8.53	10.89	18.07	11.38	9.5	7.88	11.82	21.64
Variance	4.87	3.47	7.73	3.6	3.87	3.3	5.18	9.23
Market Risk Adjusted Performance	(0.87)	0.1406	0.4902	(0.67)	(0.46)	1.9	0.5606	0.0866
Risk Adjusted Performance	(0.04)	0.0249	0.0583	0.1487	(0)	0.122	0.0623	0.0212
Skewness	0.3883	(0.06)	1.84	0.8118	0.801	0.3421	0.673	3.6
Semi Deviation	N/A	1.64	1.73	1.1	N/A	1.18	1.69	1.7
Information Ratio	(0.11)	(0.02)	0.0495	0.1812	(0.06)	0.1367	0.0496	(0.01)
Value At Risk	(3.18)	(3.60)	(3.93)	(2.15)	(3.20)	(2.63)	(2.93)	(2.76)
Expected Short fall	N/A	(1.63)	(2.60)	(1.73)	N/A	(1.83)	(1.95)	(2.19)
Downside Deviation	N/A	3.14	2.38	1.52	N/A	1.56	1.85	1.79
Semi Variance	N/A	2.69	2.99	1.21	N/A	1.39	2.86	2.88

Bio View Competition Performance Charts

Five steps to successful analysis of Bio View Competition

Bio View's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Bio View in relation to its competition. Bio View's competition analysis typically involves several steps, including:

Identifying the key players in the market: This involves identifying the major competitors of Bio View in the market, both direct and indirect, as well as new entrants and disruptive technologies.
Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Bio View's competitive landscape.
Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Bio View, and developing a strategy to address them.
Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.

Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Bio View position

In addition to having Bio View in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Gambling Thematic Idea Now

Gambling

Companies that are related to providing gambling services across multiple geographical areas by investing, exploring, or producing software, hardware, and related infrastructure for running gambling operations or trading speculative assets. The Gambling theme has 38 constituents at this time.

You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Gambling Theme or any other thematic opportunities.

View All Next

Launch

Check out Bio View Correlation with its peers.

You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Complementary Tools for Bio Stock analysis

When running Bio View's price analysis, check to measure Bio View's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bio View is operating at the current time. Most of Bio View's value examination focuses on studying past and present price action to predict the probability of Bio View's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bio View's price. Additionally, you may evaluate how the addition of Bio View to your portfolios can decrease your overall portfolio volatility.

	Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
	ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
	Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
	Portfolio Anywhere Track or share privately all of your investments from the convenience of any device
	AI Investment Finder Use AI to screen and filter profitable investment opportunities
	Commodity Directory Find actively traded commodities issued by global exchanges
	Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk
	Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
	Commodity Channel Use Commodity Channel Index to analyze current equity momentum
	Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios
	Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years
	Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets

Please note, there is a significant difference between Bio View's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bio View is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bio View's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Bio Competitors

Specify up to 10 symbols:

Bio View Competition Correlation Matrix

Risk-Adjusted Indicators

Bio View Competitive Analysis

Bio View Competition Performance Charts

Five steps to successful analysis of Bio View Competition

Complement your Bio View position

Did You Try This Idea?

Run Gambling Thematic Idea Now

Gambling

Complementary Tools for Bio Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY